Germany’s CureVac Receives EU funding for mRNA COVID-19 Vaccine Development

German COVID-19 vaccine developer CureVac has been awarded a €75 million loan from the European Investment Bank 
$ARCT $VXRT $SRNE $INO $HTBX #EU #investment #stocks #vaccine https://t.co/W02GkPDiYT